Aster DM Healthcare PAT at Rs 107 cr. in Q2FY22
Aster DM Healthcare announced its financial results for the quarter ended September 30, 2021
Aster DM Healthcare announced its financial results for the quarter ended September 30, 2021
Glycopyrrolate injection can also be used in adults as an adjunctive therapy for the treatment of gastrointestinal ulcer when a rapid effect is desired or when oral medication is not tolerated
The Thermo Scientific Orbitrap Exploris MX enables customer success by combining high-quality data with operational simplicity
New bioinformatic workflow advances analysis capabilities for whole-exome assessment and interpretation
The Akovaz brand and generic market had U.S. sales of approximately US $ 67.5 million MAT for the most recent twelve months ending in August 2021
The collaboration provides KardiaMobile users quick access to doctors worldwide for consultations about their ECG readings
Two leaders in science combine complementary best-in-class technologies for biologics manufacturing customers
Acute therapies continue to report strong growth compared to chronic ones.
Combination of hardware and data analytics software improves real-time and remote patient monitoring; digitizes and automates time-consuming and critical tasks for medical personnel, reducing administrative tasks by 35 per cent
The collaboration aims to deliver greater insights to the oncology fraternity, predict patient therapy responses and enable therapy selection resulting in optimal treatment outcomes.
Subscribe To Our Newsletter & Stay Updated